Clinical trial
Ischemic and Bleeding Outcomes After Angiolite Stent Implantation and an Abbreviated Dual Antiplatelet Therapy. A 2x2 Factorial, All-comer, Multicenter, Randomized Controlled Trial: ANGIODAPT
NCT05952206 is registered in ClinicalTrials.gov with iVascular S.L.U. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Ischemic and Bleeding Outcomes After Angiolite Stent Implantation and an Abbreviated Dual Antiplatelet Therapy. A 2x2 Factorial, All-comer, Multicenter, Randomized Controlled Trial: ANGIODAPT
- Lead sponsor
- iVascular S.L.U.
- Phase
- Phase 3
- Overall status
- Active, not recruiting
- Start date
- October 13, 2023
- Completion date
- January 13, 2030
- Enrollment
- 2,312 (actual)
- Sites
- 38
Conditions
As the registry lists them; a condition with its own page is linked.